|
Delayed
Bombay S.E.
02:40:02 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 2,279.30 INR | -3.14% |
|
-5.42% | +43.18% |
| 07-30 | Hester Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 07-30 | Hester Biosciences Limited, Q1 2027 Earnings Call, Jul 30, 2026 |
| Market Cap | 20.02B 210M 180M 169M 154M 291M 293M 2B 775M 10.1B 788M 771M 33.45B | P/E 2025 |
38.8x | P/E 2026 | 19.3x |
|---|---|---|---|---|---|
| Enterprise Value | 21.9B 230M 197M 185M 169M 319M 320M 2.19B 848M 11.05B 862M 843M 36.6B | EV / Sales 2025 |
4.11x | EV / Sales 2026 | 3.78x |
| Free-Float |
31.22% | Yield 2025 |
0.56% | Yield 2026 | 0.87% |
Last Transcript : Hester Biosciences Limited
| 1 day | -3.14% | ||
| 1 week | -5.42% | ||
| Current month | -8.17% | ||
| 1 month | -9.86% | ||
| 3 months | +5.88% | ||
| 6 months | +44.40% | ||
| Current year | +43.18% |
| 1 week | 2,275.5 |  | 2,440 |
| 1 month | 2,275.5 | | 2,669 |
| Current year | 1,250.95 | | 2,669 |
| 1 year | 1,250.95 | | 2,669 |
| 3 years | 1,246.75 | | 3,375.45 |
| 5 years | 1,246.75 | | 3,375.45 |
| 10 years | 666 | | 3,375.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 1987-04-28 | |
Ashish Desai
DFI | Director of Finance/CFO | - | 2025-11-19 |
Vinod Mali
CMP | Compliance Officer | - | 2018-05-13 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 83 | 2005-04-20 | |
| Director/Board Member | 64 | 1987-04-28 | |
| Director/Board Member | 61 | 1987-04-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.14% | -5.42% | +7.54% | +33.12% | 210M | |
| +0.30% | +1.10% | -49.92% | -57.60% | 32.03B | |
| -0.04% | +2.37% | +40.11% | +111.65% | 12.53B | |
| +0.12% | -3.23% | -20.72% | +4.23% | 3.89B | |
| -1.05% | -0.45% | -2.95% | +19.02% | 3.24B | |
| +1.93% | -5.94% | +41.09% | +37.42% | 2.05B | |
| +0.91% | +1.70% | +9.50% | +21.28% | 1.99B | |
| +0.45% | +1.83% | +10.57% | +140.92% | 1.46B | |
| +0.81% | -7.22% | -25.55% | +0.34% | 1.14B | |
| +1.49% | +0.29% | -11.18% | -40.04% | 1.05B | |
| Average | +0.18% | -0.23% | -0.15% | +27.03% | 5.96B | |
| Weighted average by Cap. | +0.24% | +0.96% | -18.58% | -1.30% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.12B 32.76M 28.12M 26.39M 24.11M 45.49M 45.71M 312M 121M 1.58B 123M 120M 5.22B | 3.34B 35.03M 30.07M 28.22M 25.78M 48.64M 48.88M 334M 129M 1.69B 132M 129M 5.58B |
| Net income | 275M 2.88M 2.47M 2.32M 2.12M 4M 4.02M 27.48M 10.65M 139M 10.82M 10.59M 459M | 556M 5.83M 5.01M 4.7M 4.29M 8.1M 8.14M 55.62M 21.55M 281M 21.9M 21.43M 930M |
| Net Debt | 2.16B 22.69M 19.47M 18.28M 16.69M 31.5M 31.66M 216M 83.82M 1.09B 85.19M 83.34M 3.62B | 1.88B 19.74M 16.94M 15.9M 14.52M 27.41M 27.54M 188M 72.93M 950M 74.11M 72.5M 3.15B |
Employees
483
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | ₹2,279.30 | -3.14% | 439 |
| 26-08-26 | ₹2,353.30 | -2.06% | 917 |
| 26-08-25 | ₹2,402.75 | +1.77% | 235 |
| 26-08-24 | ₹2,361.00 | -1.04% | 228 |
| 26-08-21 | ₹2,385.90 | -0.81% | 324 |
- Stock Market
- Stocks
- HESTERBIO Stock
Select your edition
All financial news and data tailored to specific country editions
